Birgitta Versluijs

153 Outcome predictors in Allo-LS in children TABLE S6. PFT in BOS patients, univariate analyses for association with Allo-LS free survival Hazard ratio (95% CI), P value PFT at diagnosis BOS (n=17) FEV1% 0.96 (0.91-1.02), p=0.19 FVC% 1.02 (0.97-1.07), p=0.55 FEV1/FVC 0.94 (0.90-0.990, p=0.02 RV/TLC 1.01 (0.94-1.09), p=0.83 PFT after first MP pulse (n=17) FEV1% after MP1 0.94 (0.89-0.98), p=0.01 FEV1% after MP1 below the median of 55% 8.03 (0.96-67.3), p=0.06 Increase in FEV1% after MP1 0.84 (0.73-0.96), p=0.01 Increase in FEV1% below the median of 10% after MP1 9.75 (1.14-83.6), p=0.04 PFT = Pulmonary Function Test, BOS = Bronchiolitis Obliterans Syndrome, Allo-LS = Alloimmune Lung Syndrome, FEV1% = Forced Expiratory Volume in 1 second as a percentage of normal values, FVC% = Forced Vital Capacity as a percentage of normal values, RV = Residual Volume, TLC = Total Lung Capacity, MP1= First Me- thyl Prednisolone pulse 8